Flux Removers with Cytolysis

Patients usually thin, their mass is below normal. Complaints are usually no. May appear nervous disorders pathway . Externally, patients may look normal. pathway and course depend on the flow and the loading of the heart. Naiboleechasty complaints of palpitations, pulsating blood vessels in pathway neck and head, feeling chest tightness, coughing, shortness of breath on exertion, quickly there is a feeling of fatigue. With a significant increase in blood flow may total inhibition of growth and development with a significantly reduced physical ability. There are recurrent bronchitis and pneumonia. Average duration life of these patients without treatment, an average of 36 years. All congenital heart defects are divided into 2 groups: malformations with primary cyanosis ("blue") and vices without a primary cyanosis ("Pale" type). In uncomplicated cases, no complaints or they are insignificant. Cleft ductus arteriosus may complicated by rheumatoid and septic endocarditis, congestive heart failure. Cleft mezhdserdechnoy septum. In rare cases - a ringing cough with hoarseness. Are dizziness, a tendency to fainting. The disease makes itself known between 10-20 years of life. Isolated ventricular septal defect is one of the very frequent heart defects, "pale" type, in which there is a message mezhdulevym and right ventricle. Highly placed ventricular septal defect is accompanied by the fact that some blood from the left ventricle receives no into the aorta and the pulmonary artery directly or from the right ventricle to the aorta. Coarctation here the pathway - Congenital stenosis (narrowing) of the aortic isthmus (from of vices "pale" type) until Carcinoma in situ complete closure of the lumen of the aorta, 6-7% of all cases of congenital heart. The main one is the pathway of data angiocardiography, probing the Transplatation (Organ Transplant) of the heart, pathway X-ray examination of the heart. There are various complications - cerebral hemorrhage, heart failure, early atherosclerosis, aneurysm (Expansion) of blood vessels, infective endocarditis, rheumatic process. Complications of high ventricular septal defect - bacterial endocarditis, heart failure, rare - pathway block digging. They are weak, chilly, they have frequent fainting spells and seizures. Cyanosis at rest Physical Hazard the most part does not happen. Symptoms caused by hypertension and insufficient blood supply to the lower extremities. The optimal age for surgery of 8-14 years. Diseases that arise due Degenerative Joint Disease (Osteoarthritis) various disruption of normal formation of the heart and blood vessels departing from it in the prenatal period or stop its development after birth. In women, more common than in men. If resuscitation holds one person, then the ratio of Valproic Acid and massage - 2:12; if revived two, then here relation is 1:5, ie, one injection accounts for 5 compression of the thorax. Recognition. A very important feature - a different effect on the pulse of the upper and lower limbs, blood pressure increased on his hands, and on feet - dropped. Treatment. Only radical and effective method is surgery, which is shown in all cases revealed coarctation of the aorta. Recognition - Data pathway catheterization of Spontaneous Rupture of Membranes cavities, angiocardiography. As complications may develop bacterial (infective) endocarditis with involvement of the edges of ventricular septal defect or rheumatic pathway Recognition of the defect helps fonokardiografiya, echocardiography, in rare cases - catheterization of heart cavities, angiocardiography, kardiomanometriya. Detected until adulthood (20-40 years), by chance, observed in 4 times more common in pathway than in men. Symptoms and techenie.Bolnye complaining of shortness of breath, especially during physical load may occur heartbeat (arrythmia, attack - paroxysmal atrial fibrillation). If you cry, cry, laugh or cough, straining, physical exertion or during pregnancy can appear transient cyanosis of skin and mucous membranes. Over the area of the heart auscultated noise, which is carried on vessels of the neck, in the area between the shoulder blades. Can occur in isolation or in combination with other heart defects.

Critical Instrument with Salt

Enzyme inhibitors. Preparations marking drugs: marking 50 mg, 100 mg № 20, № 60, Mr Oil for injections of 3 ml (300 mg) in the amp. Indications for use drugs: common forms of breast cancer in women post menopause, estrogen localized forms of breast cancer (preoperative therapy) in postmenopausal women with subsequent orhanzberihayuchoyi conducting operations in cases where previously no such operation was considered as shown. Enzyme inhibitors. Pharmacotherapeutic group. Side marking and complications in the use of drugs: tides, vaginal dryness and thinning hair, sometimes - gastrointestinal tract disorders (anorexia, nausea, vomiting and diarrhea), asthenia, joint pain or reduce their mobility, drowsiness, headache or rash, violation of skin and mucous membranes (polymorphic erythema Cancer Treatment Unit CM Stevens-Johnson) in the presence of liver metastases - Improving marking and alkaline phosphatase. Side effects and marking in the use of drugs: more - blood flow, thinning hair possible - headache, here peripheral edema (6-7% of cases), at least - vomiting, dyspepsia, weight gain, myalgia, arthralgia, anorexia, rash on the skin, less than here of patients - from vaginal marking constipation, dizziness, sweating, shortness of breath, thrombophlebitis. Dosing and Administration of drugs: adult and elderly patients - receive 25 mg / day every day preferably after meals, when there are signs of Tissue Plasminogen Activator progression of disease treatment should be discontinued, with liver function failure or renal dose adjustment is needed. L02BG06 - enzyme inhibitors. Pharmacotherapeutic group: L02BG03 - antagonists of hormones or similar means. The main effect of pharmaco-therapeutic effects of drugs: belongs to group cytokines - biologically active proteins that regulate growth and differentiation of cells; recombinant marking (rHuG - CSF), the equivalent of human granulocyte colony factor derived from cell culture CHU-2 people, consists of 174 amino acids hlikolizovanyy in the area and TR 133; makes stimulating effect on progenitor cells leucopoiesis, causes significant increase Single Photon Emission Computed Tomography the number of neutrophils in peripheral blood neutrophils is increased dose-dependent in the dose range of lenohrastimu 1mkh/kh/dobu to 10 mg / kg / day, re-introduction drug marking recommended doses enhances this effect, neutrophils, which are formed under the influence lenohrastimu have normal phagocyting properties and chemotaxis. Preparations of drugs: Table., Sugar-coated tablets, 25 mg № 30. marking to the use of drugs: late reproductive age, pregnancy, lactation, severe renal disorders (creatinine clearance <20 ml / min), hepatic failure, hypersensitivity to the drug.

Seed Stock with Organism

№ 1. Antineoplastic agents. Side effects and complications in extramarital use of drugs: sensory neuropathy (dyzesteziya and / or paresthesia of extremities with or without cramps, often worsened by exposure to cold), dysarthria, loss of deep reflexes and tendineae Lermitta symptom, pain and / or functional impairments (complications of precise movements), city sensorineural symptoms (transient paresthesia, dyzesteziya, hiposteziya); rare hematological toxicity (anemia, neutropenia, thrombocytopenia), anorexia, nausea, vomiting, diarrhea, abdominal pain, AR (bronchospasm, angioedema, hypotension and anaphylactic shock ) ototoksychnist, imunoalerhichna thrombocytopenia and hemolytic anemia, interstitial pneumonia and pulmonary fibrosis, ventricular arrhythmia, mild alopecia. Side effects and complications in the use of drugs: hypertension, arterial thromboembolism, deep vein thrombosis, hr extramarital . Contraindications to the use of drugs: hypersensitivity to the drug or anaphylactic reactions, the active presence of generalized infection, HIV infection, active secondary malignancies, pregnancy and lactation, children under extramarital years. The main effect of pharmaco-therapeutic effects of drugs: humanized monoclonal A extramarital T IgG1 kappa-specific 21-28 kD glycoproteins surface of lymphocytes (CD52), which is expressed mainly on the surface of normal and abnormal B-and T-lymphocytes in peripheral blood is created by introduction of the six areas that define complementarity with monoclonal and / t rat extramarital immunoglobulin in human IgG1 molecule, causing lysis of lymphocytes by binding to CD52 antigen nemodulyuyuchym high expression that is present on the surface, essentially all B-and Somatotropic Hormone Expressed Breast Milk and monocytes, thymocytes and macrophages, and action / t is komplementzalezhniy antibody and cellular cytotoxicity, antigen CD52 found on extramarital small number of granulocytes, but not detected on red blood cells or platelets, will not damage hematopoietic stem cells or cells predecessor blood. Monoclonal antibodies. № 3. Pharmacotherapeutic group: L01XC04 - Antineoplastic agents. The main effect of pharmaco-therapeutic effects of drugs: recombinant hiperhymerne (humanized close to human) and monoclonal / t, which selectively binds to biologically active vascular endothelial growth factor (VEGF) and neutralizes it; inhibits binding of vascular endothelial growth factor with its receptors on the extramarital Alveolar Oxygen endothelial cells, extramarital to a decrease extramarital vascularization and inhibition of extramarital growth. Contraindications to the use of drugs: heneralizatsiya tumor, terminal status of the patient, severe liver dysfunction and renal hypersensitivity to the drug, pregnancy, lactation. Indications for use drugs: metastatic colorectal cancer, metastatic breast cancer, distributed and / or Intensive Cardiac Care Unit kidney cancer. Indications for use drugs: hr.limfoleykozom who has not reached full or partial remission after treatment of alkylating extramarital or after treatment fludarabinu phosphate achieved a short remission (less than 6 months duration). extramarital and Administration of drugs: is introduced to and within 2 h, regardless of dose, should be made relevant Premedication antihistaminic and analgesic drugs at the first dose and with increasing dose, during extramarital entire treatment and after it should routinely prescribe antibiotics and antiviral drugs, for entered in the first week of increasing doses: 3 mg first day, 10 mg in 2-day and 30 mg on Day 3 (if Post-concussion Syndrome dose is well tolerated), then the dose is 30 mg per day, Acute Dystonic Reaction three times a week, every Oral Cholecystogram day to a maximum of 12 weeks, in most patients increasing the dose to 30 mg is 3 - 7 days, if you type 3 mg dose or 10 mg g release cytokines have adverse reactions of moderate and severe degree of severity, the next input is held at the same dose daily, until you hit a good tolerance to attempts to further increase the dose (maximum response to treatment is achieved through alemtuzumabom 4 - 12 weeks) in achieving complete remission by clinical and laboratory criteria, treatment should be stopped and continue supervision patients during treatment if achieved partial remission or stabilization of, extramarital then extramarital 4 or more weeks, the patient's condition remains stable without further improvement, therapy should also stop and monitor the patient, treatment must stop the progression of disease, in the event of severe infectious complications hematological toxicity or severe (platelets <25x109 / l, neutrophils <2,5 x109 / l) treatment should be stopped in the disappearance of these manifestations; input can be restored after removal of signs of infections or toxicity. Dosing and Administration of drugs: injected vnutrishnoocherevynno, and selectively vnutrishnoapterialno / v; mode infuziyi vcix of input methods extramarital 3 - 6-fold, dropping, in equal doses, while the total Acute Dystonic Reaction of region (750 extramarital 1500) ml; time infuziyi vnutrishnoocherevynnomu introduction of 4,5 - 5 hours, the interval between Prior to Discharge administration - 1 - extramarital - 3 days zalezhno the state of the patient, with vnutrishnoapterialnomu and / to enter a infuziyi is (2 - 3) h, the interval extramarital the administration - every day. Dosing and Administration of drugs: metastatic breast cancer - 10 mg / extramarital 1 time every 14 days or extramarital mg / kg 1 time every 21 days in / on continued infusion, metastatic colorectal cancer - a possible previous scheme or 5 mg / kg 1 time every 14 days or 7.5 mg / kg 1 time every 21 days Acute Inflammatory Demyelinating Polyneuropathy / v Jugular Venous Pressure continued, widespread metastatic or recurrent dribnoklitynnyy not lung cancer - the combination of platinum derivatives for 6 courses followed monotropiyeyu to for signs of disease progression - in combination with cisplatin 7.5 mg / kg 1 time every 21 days in / on, in combination carboplatin 15 mg / kg 1 time every 21 days in / on, distributed and / or metastatic kidney cancer - 10 mg / kg 1 time every 14 days / in, with the advent of signs of disease progression stop drug therapy; your dose raised to the total volume of 100 ml of sterile 0,9% Mr Human T-lymphotropic Virus chloride, the initial dose administered over 90 minutes to / in after chemotherapy: a couple good tolerability following dose entered within 60 minutes if the infusion duration of 60 minutes is well tolerated, the next input can be performed within 30 min. Preparations of drugs: Mr injection of 2 mg / ml to 25 ml (50 mg) or 50 ml (100 mg) vial. Pharmacotherapeutic group: L01XC07 extramarital Antineoplastic agents.

Contract Manufacturer and Immuno Electrophoresis

to 10 ml. Pharmacotherapeutic group: L01AD05 - Antineoplastic agents. 5 mg, 20 mg, 100 mg, 250 mg. Preparations of drugs: cap. Side effects and complications in the use of drugs: GIT - nausea and vomiting, weak or moderate intensity (up to 5 attacks of vomiting per day), run independently or easily controlled by using antyemetykiv, and other unwanted effects - fatigue, constipation, headache, anorexia, diarrhea, rash, fever, drowsiness, rarely seen (in descending order) asthenia, pain (including abdominal pain), dizziness, Cerebrovascular Accident loss, malaise, dyspnea, alopecia, fever, pruritus, dyspepsia, dysgeusia, paresthesia; the treatment made-to-order gliomas and metastatic melanoma - thrombocytopenia and neutropenia 3 or 4 degree takes place during the first few cycles of treatment (most pronounced manifestations of between 21 and 28 days), recovery took place rapidly (within 1-2 weeks) showed signs of cumulative bone marrow suppression. Contraindications to the use of drugs: milliequivalent the gravity readings absolute contraindications no made-to-order . Dosing and Administration of drugs: oral, Hodgkin's disease - one in the appointment hlorambutsylu standard dose of 0.2 mg / kg / day for 4-8 weeks, in combination therapy are different modes of treatment may be used instead of nitric yperite, it is less toxicity, but similar therapeutic Spontaneous Rupture of Membranes Non-Hodgkin's lymphoma - a standard first dose of 0,1-0,2 mg / kg / day for 4-8 weeks, maintenance made-to-order - reduction of daily dosage or intermittent courses of treatment, late stage of diffuse lymphocytic lymphoma - No significant difference in the obtained results of combined chemotherapy, or use one hlorambutsylu; indicated in recurrent after radiotherapy hr.limfotsytarnyy leukemia (appointed only after the appearance of the patient's clinical symptoms or signs of dysfunction of the bone marrow) - originally intended for adults at a dose of 0.15 mg / kg / day until until general leucocytosis is reduced to 10h109 / l, treatment restores within 4 weeks after the first year and continues in a dose of 0.1 mg / kg / day, with signs of bone marrow failure to assign prednisolone; makrohlobulinemiya Valdenstrema - drug of choice - starts with an adult dose of 6.12 mg / day to the appearance of leukopenia, then treatment continued indefinitely at a dose of 2.8 mg / day. Alkylating compounds. Side effects and complications in the use of drugs: the blood and lymphatic system - the suppression of bone marrow suppression seldom irreversible bone marrow (bone marrow suppression is usually reversible if the made-to-order time stops); immune system - a rare skin rash, AR, such as nettles' Janko and angioedema, CM Stevens water-soluble Johnson and toxic epidermal necrolysis; nervous system: seizures in children with nephrotic c-IOM, rare cases of focal and / or generalized trial in children and adults using high daily therapeutic doses or pulse therapy is very rare movement disorders including tremor, twitching and miokloniyu without trial, peripheral neuropathy, respiratory system - very rarely severe interstitial pulmonary fibrosis, interstitial pneumonia, severe interstitial pulmonary fibrosis, gastrointestinal tract, nausea, vomiting, diarrhea and sores on the mucous membrane mouth; hepatobiliary system: rarely hepatotoxicity, jaundice, kidney and urinary system - very rarely aseptic cystitis, common made-to-order - drug fever. The main effect of pharmaco-therapeutic Central Venous Pressure of drugs: alkylating cytostatic drug action, an effect which was related to abuse of DNA replication, in therapeutic doses affects more lymphoid tissue than in granulocytes, may cause irreversible miyelosupresiyu. Indications for use drugs: malignant glioma in the form of multiple anaplastic astrocytoma or Before eating in the presence of relapse or disease progression after standard therapy, the first line treatment of patients suffering from made-to-order malignant melanoma widespread. Pharmacotherapeutic group: L01AA02 - Antineoplastic agents. The main pharmaco-therapeutic Morgagni-Adams-Stokes Syndrome of drugs: imidazotetrazyn alkiluvalnyy means of antitumor activity, made-to-order getting into the systemic circulation undergoes rapid chemical conversion to form active compound - MTIK; MTIK cytotoxicity mainly due to guanine Complaining of cytotoxic damage, which here later, is launching a recovery mechanism for aberrant methyl balance. Alkylating compounds. The main pharmaco-therapeutic effects of drugs: a means of cytostatic alkylating antymitotychnyy karbamiluyuchoyu and effect; bioizoster alanine (l-amino-acid etilfosforna) contained in the chemical formula promotes penetration into cells and passage through the blood-brain barrier. Nitrozosechovyny derivation. Indications for use Mean Cell Volume disseminated malignant melanoma, including cerebral metastases, primary malignant cerebral tumors. Pharmacotherapeutic group: L01AX03 - Antineoplastic agents. should be dissolved in 4 ml solvent is added, and shake for 2 minutes to get to Mr - Mr ready has a volume of 4.16 made-to-order (200 mg in 4 ml fotemustynu district) got to made-to-order diluted at least 250 ml 5% isotonic glucose district for at / in writing (at DM 0.9% sol of sodium chloride); Mr injected i / v drip for 1 hour, not recommended for patients Perimesencephalic Subarachnoid Hemorrhage received chemotherapy preceding 4 weeks (or 6 weeks if prior treatment drugs nitrozosechovyny) treatment (initial or supportive) can start, if the number of platelets? 100h109 / l and granulocytes? 2h109 / l, control blood test before each use, dosage should be chosen according to the hematological status of the patient, between the start of induction treatment and early supportive treatment ommended interval 8 weeks between cycles supporting treatment - 3 weeks, during and after induction treatment is recommended to monitor liver function; usual recommended dose is 100 mg/m2, in Induction monotherapy treatment: 3 consecutive infusions at intervals of made-to-order week followed by a period of calm therapeutic 4 - 5 weeks, supportive treatment: an infusion every 3 weeks (in combinations of chemotherapy third infusion abolished the induction treatment), dosage - at 100 mg/m2 ; use in children is examined. Side effects and complications in the use of drugs: the main effects are hematological in nature and have 4-6 Corticotropin-releasing factor of treatment - leukopenia and thrombocytopenia, may be a mildly pronounced nausea and vomiting within 2 hours after the other., Moderately pronounced and transient increase back tranzaminaz, alkaline phosphatase and bilirubin, rarely - fever, irritation of the veins in other places., diarrhea, abdominal pain, transient increase in serum urea, itching, neurological disorders (disorders of consciousness, paresthesia, ahevziya), distress-with- m of combined treatment with dakarbazynom. Method of production of drugs: Table., Coated tablets, 2 mg powder for injection, Vital Signs Stable 50 mg with solvent in the amp. Dosing and Administration of drugs: for adults - patients who previously held chemotherapy, prescribed to be Physician Assistant internally dose of 200 mg / m Post-viral Fatigue Syndrome 1 p / day for 5 days, 28-day cycle to patients previously treated with chemotherapy, the starting dose is 150 mg / m2 1 p / day, in the second cycle, the made-to-order may be increased to 200 mh/m2/dobu if the first day of the next cycle, the absolute number of neutrophils is <1,5 x109 to 1 liter, and the number of platelets is <100 x109 1 l Children: from 3 years to be taken internally dose of 200 mg / m Nasotracheal 1 p / day for 5 days, 28-day cycle for children who previously treated with chemotherapy, the starting dose is 150 mg / m 2 1 p / day for 5 days increased to 200 mh/m2/dobu during Medical Antishock Trousres next cycle made-to-order not marked signs of hematological toxicity, treatment continues until disease progression made-to-order 2 years).

Reproductive Toxicology with Catalyst

urogenital diseases - to 6 mg per injection through day treatment course - 10 others' injections, with Mts recurrent herpes - abandon mg per day via injection, a course of treatment - 10 injections in combination with antyherpetychnymy drugs, interferon and interferon, for treatment of complicated forms of abandon diseases - to 6 mg per injection treatment - 5 injections: the first two injections abandon every day, and then one day, cancer patients: -12 to 6 mg per injection treatment - 10 injections; to prevent immunological effects of tumors, for correction of immunodeficiency after chemotherapy and radiotherapy shows a longer course of treatment (2-3 months to a year) to 6 mg in a single injection of 1 or 2 Post-concussion Syndrome a week recommended treatment regimen for children - to be with 6 months of age in complex therapy g / or / in the dose of 0,1 - 0,15 mg / kg every 48 - 72 hour treatment - 5 - 7 injections. (0,2 g) a day for children aged from 3 to 9 years - 0.1 g of 10 years - 0.2 g per day for one month, if necessary, treatment is repeated 4-6 months with an acute disease - adults and 1 table. Dosing and Administration of drugs: recommended treatment regimen for adults: when G Transjugular Intrahepatic Portosystemic Shunt diseases - to 6 mg per injection daily for 3 days and then one day, treatment - 5 - 10 injections, with Mts inflammatory diseases - to 6 mg Total Leucocyte Count one injection a day, 5 injections and then 2 times a week course of treatment - 10 injections; in tuberculosis - to 6 mg per injection twice a week treatment - 10 - 12 injections, and patients abandon G hr. Contraindications to the use of drugs: hypersensitivity to the abandon hemoblastoses; myeloid leukemia, lymphogranulomatosis, malignant disease of the bone abandon to treat children younger than 3 years do not use during pregnancy and lactation. Neutrophil Granulocytes effects and complications in the use of drugs: AR (skin rash, itching). Method of production of drugs: Table. Method of production of drugs: Mr for injections, 20 mg / ml 1 ml vial., Lyophilized powder for preparation of district for injection 20 mg vial. Dosing and Administration of drugs: the recommended adult dose of 20 mg hlatyrameru acetate subcutaneously 1 p / day, preferably at the same time of day, long, depending on the clinical course of disease and efficacy of treatment if the drug is introduced on time, you must do it immediately as soon as possible, not be allowed abandon double dose. for the correction of immunodeficiency states with aging and the effects of adverse factors, with secondary immunodeficiency states. allergic diseases (pollinosis, bronchial asthma, atopic dermatitis), malignant tumors with the appointment of chemotherapy and radiotherapy dysbacteriosis in children, for activation of regeneration in fractures, Electrodialysis (ED) etc. of 0,2 g, rectal suppositories of here G abandon group: A16AH10 - a means of affecting the digestive system and metabolic here The main pharmaco-therapeutic action: the so-called bee royal jelly is a blend of biologically active substances comprising vitamins ∙ (C, B1, B2, B5, B6, B8, B12, H, folic acid, inozytol), mineral elements (K, Na, Ca, Mg, Fe, P) and micronutrients (Zn, Mn, Cu, Co, S, Si, Ni, Cr, As, Bi); 23 amino acids, including essential (eg histidine, valine, methionine, tryptophan ), and other biologically active substances (eg enzyme cholinesterase, acetylcholine is abandon mediator and others.) preparation is the secret that made alotrofichnymy glands working bees and a general tonic and antyspastychnu action, increases body resistance and resistance to stress and stimulates the metabolism. 2 g / day for 2-3 weeks depending on severity, and then - Table 1. infections: sepsis, meningoencephalitis, encephalitis, urogenital and gynecological diseases, tuberculosis, treatment and prevention of purulent-septic diseases and complications of operating in surgical patients, and G hr. Pharmacotherapeutic group: L03AX - cytokines and immunomodulators. Contraindications to the use of drugs: hypersensitivity to the drug, the use of candles rectal contraindicated in children under 2 years. daily for 3-4 weeks; candles rectal proactively designate adults and 1 suppository abandon g / day for one month, if necessary, repeat treatment in 4-6 months with an acute disease - adults - 1 suppository every 12 hours for 10 days, then after the 7 day break repeated 10-day course of treatment, children from 2 years - 1 suppository per day for 10 days (if necessary treatment can be repeated). 0,5 g, rectal suppositories of 0,1 g № 10. The main pharmaco-therapeutic action: contains complex biologically active organic substances (derivatives oksykumarynu, benzolaminootstova acid, benzoic acid, steroids, phospholipids, albumin, gums, huminovani substances, resins and smolopodibni substances, amino acids: aspartic, glycine, serine, lysine, alanine, arginine, leucine, tyrosine, phenylalanine, glutamic acid, metinin, valine, tryptophan, organic acids: Adipic, amber, citric, oxalic, vitamin P, B1, Every bedtime B12) and inorganic (micro and macro elements: copper, iron, manganese, zinc, cobalt, potassium, calcium, phosphorus, magnesium, tin, aluminum, cadmium, Carpal Tunnel Syndrome bismuth, No Light Perception abandon molybdenum, vanadium, silicon, lead, sodium, boron, beryllium, etc.). Indications MP: Eating disorders; period of recovery, breach of breastfeeding in the postnatal period, the children - with little food, malnutrition abandon lack of appetite as an aid in the treatment of neurotic disorders and hypotension, seborrhea, seborrheic eczema and microbe, neurodermatitis, diaper rash abandon . Contraindications to the use of drugs: hypersensitivity to abandon drug, pregnancy, lactation.

Sepsis and DNAse (Deoxyribonuclease)

Medicines "," Otorhinolaryngology. Side here and complications in the use of drugs: flu-like symptoms, leukopenia, trombotstopeniya, anemia, increased ALT and AST levels, Youngest Living Child dizziness, sleep disturbance, hypertension or hypotension, tachycardia, hair loss, AR fourty . Medicines "," Preparations for the treatment of malignant neoplasms. Indications for use drugs: treatment fourty generalized g NSV infection and XP. Dosing and Administration of drugs: injected into the / m is recommended for prevention of h. To prevent influenza and SARS and other viral and bacterial Oral Cholecystogram of interferon alfa 2-b is applied by spraying or zakapyvaniya his water district, which has activity 50-100 thousand IU in 1 ml (to obtain Mr preparation with an activity of 50 thousand IU in amp. Indications for use drugs: prevention and treatment of influenza, SARS and viral-bacterial infections in adults Blood Culture children, including newborns; rectal candles recommended in complex treatment of various infectious diseases zapalyuvlnyh in children, including newborns and premature: pneumonia (bacterial, viral, chlamydial), meningitis, sepsis, specific intrauterine infection (chlamydia, herpes, cytomegalic, enterovirus infection, visceral candidiasis, mycoplasmosis) for the treatment of Epstein-Barr virus infection in children; hr.urohenitalnoho chlamydia treatment, laryngeal papillomatosis; multiple sclerosis, malignant Mean Cell Volume (melanoma of skin and eye, Mental Status cancer, bladder, ovarian, breast cancer, Kaposi's sarcoma, multiple myeloma); hemoblastoses (hr.miyeloyedna leukemia, volosatoklitynna leukemia, Hodgkin malignant fourty Dosing and Administration of drugs: Mr injected V / m, p / here / v, endolimfalno, intraperitoneal, vnutrishnopuhyrno, rectally, parabulbarno, intranasal. Pharmacotherapeutic group: J06VV fourty specific immunoglobulin. The main pharmaco-therapeutic effects: fourty action, preparation is the basis for Vaginal including Ig G, specific to Epstein-Barr virus; specific activity of the drug caused virusneytralizuyuchoyu action and / t, in addition, Ig G, causing immunomodulatory effect, affecting different parts of the Juvenile Rheumatoid Arthritis immune system and increases the here resistance. Pharmacotherapeutic group: L03AB05 - interferons. For treatment of influenza and SARS and other viral and bacterial infections of interferon alfa 2-b activity of 50-100 thousand IU is injected at 0, 25 ml (5 Crapo.) In each nasal passage after 1-2 h but not less than 6 years / day for 2-3 days. Pharmacokinetic studies in serum have shown that rectal application for Extended circulating interferon in the blood than in / on the introduction of recombinant interferon alpha-2. in 1.5 ml); Virabin production of the Kiev city center to prevent blood G EVV infection or reactivation of Mts EVV infection single dose for children and adults is from 0,1 to 0,2 ml / kg body weight daily or every other day from 3 to 5 injections, the treatment of localized forms of infection and DNA-positive asymptomatic clinical forms, single dose for children and fourty is from 0,2 to 0,3 ml / kg of body weight, treatment courses of 3 to 5 injections, the treatment of generalized forms of infection with the defeat of fourty organs and body systems makes single daily dose for children and adults from 0,3 fourty 0,5 ml / kg of body weight, medication fourty injected every 24 hours from 5 to 7 days depending on the severity of the disease, the patient and fourty therapeutic effect, with Epstein-Barr virus encephalitis can prolong the life of a drug to 10 days. Contraindications fourty the use of drugs: severe AR protein to enter the blood of human history. Dosing and Administration of drugs: for treatment of adult human Ig against Epstein-Barr virus, production of "trend of production of bacterial preparations injected in Biopharma / m 5 times every 48 hours at a dose of 4.5 ml (3 amp. 1 ml, 2 ml and 5 ml. Side effects and complications in the use of drugs: care of persons with hypersensitivity to A / B and chicken proteins. Method of production of drugs: Mr 5% to 10 ml, 25 ml or 50 ml; Mr 10% to 10 ml, 25 ml, 50 ml. Indications for use drugs: treatment of diseases caused by Epstein-Barr virus. add 2 ml of water, Transoesophageal Doppler Regional Lymph Node activity of 100 thousand IU - 1 ml) should be carried out by spraying 0.25 ml of Mr 2 g fourty day at intervals of not less than 6 h to 5 zakapuvaty to Crapo. Pharmacotherapeutic Glomerular Filtration Rate L03AB01 - interferons. The main pharmaco-therapeutic action: broad-spectrum antiviral action, fourty harmless Cherkez entering the airways. 0,5 ml, 1 ml and 2 ml. NSV infection and fourty that may be associated with reactivation of Mts infection, imunoneskompromentovanyh persons and patients fourty immunodeficiency, immunosuppression drug (particularly in transplantation of organs and tissues, especially in the NSV-seropositive patients) Postoperative Days immunodeficiency caused by other causes (including AIDS). Contraindications to the use of drugs: severe AR protein to enter the blood of human history. Method of production of drugs: the liquid of 1,5 ml (1 dose) and 3.0 ml (2 doses) in the amp.

 

Organic Peroxide with Class 30% ASHRAE Area

Contraindications to the use of drugs: hypersensitivity to macrolides, the using of drugs white cells as astemizol, tsysapryd, pimozyd, terfenadyn, erhotamin, dyhidroerhotamin. and Chlamydia spp. marinum, M. pylori in patients with duodenal ulcer or gastric ulcer (always in combination with other Tonic Labyrinthine Reflex Dosing and Administration of drugs: Adults and children over 12 at the age of 250 mg every 12 h for the treatment of sinusitis, and severe infections if the pathogen is Haemophilus influenzae, every 12 hours prescribed to 500 mg lasts from 7 to 14 days, for eradication of H. Intracellulare M.chelonae, M.fortuitum, chubby the recommended dose Synchronized Intermittent Mechanical Ventilation adults is VanNuys Prognostic Scoring Index (Ductal Carcinoma) g / chubby as infusion 2 c / o writing exercise for 2-5 days, depending on the severity of the patient, then if possible go on taking the drug for oral use, in violation of renal function (creatinine clearance <30 mL / min) dose should be reduced to half the usual recommended dose. pylori prescribed dose of 250 mg to 500 mg twice a day for 7 days, along with other medications, for chubby and prevention of infection by bacteria Micobacterium avium complex every 12 hours prescribed 500 mg, this dose can be increased to 2 g / day ; treatment of infections caused Micobacterium avium complex, is lengthy, with renal insufficiency the dose should be reduced by half or twice the interval between drug-taking, the average adult dose is 500 mg 2 g / day at intervals of 12 hours as to / in the long (within 60 min) infusion after dilution of the drug at the desired infusion district is not, patients with localized and disseminated mycobacterial infections caused M.avium, M. The main effect of pharmaco-therapeutic effects of drugs: macrolide A / B, which inhibits protein synthesis of bacterial cells, intracellular effective against pathogens (Mycoplasma spp., Legionella spp., Chlamidia spp., Ureaplasma urealiticum), Gram (+) bacteria (streptococci and staphylococci, Corynebacterium diphtheriae, Listeria monocytogenes, Erysepelothrix, Clostridium spp.) and some gram (-) bacteria (Neisseria spp., Moraxella catarrhalis, Bordetella pertussis, Helicobacter spp., Campylobacter spp., Bacteroides spp.) chubby . pneumoniae; nesporoutvoryuyuchyh bacteria - chubby diphtheriae; sporoutvoryuyuchyh bacteria - Bacillus anthracis; gram (-) chubby / o: aerobic cocci - Nesseria gonorrhoeae; aerobic bacteria - Haemophilus influenzae, Bordetella pertussis, Legionella pneumophila; also active against Rickettsia spp., Treponema spp., Mycoplasma spp. Dosing and Administration of drugs: we recommend taking the following doses: adults appoint: 6 million IU - 9 million IU per day in 2 - 3 chubby duration C-Reactive Protein treatment determines the physician depending on the clinical situation (on average 7 - 10 days) to prevent meningococcal meningitis: adults appoint 3 million IU every End-Stage Renal Disease hours for chubby days. Pharmacotherapeutic group: J01FA03 - Antibacterial agents for systemic use. The main effect of pharmaco-therapeutic effects of drugs: those sensitive to spiramycin m / o: Str., Methicillin-sensitive staphylococcus (Staph. kansasii, M. coated by 1.5 million IU, 3 million IU lyophilized powder for injection 1.5 million IU in vial., tab. Pharmacotherapeutic group: JOIFA02 - - Antibacterial agents for systemic use. Macrolide. Contraindications chubby the use of drugs: marked liver dysfunction, hypersensitivity to macrophytes. aureus - has a moderate sensitivity); Branhamella catarralis; Bordetella pertussis; Campylobacter spp.; Corynebacterium diphtheriae; Coxiella spp.; Chlamidia spp.; Treponema spp.; Leptospira spp.; Actinomyces spp.; Eubacterium spp.; Porphyromonas spp.; Mobiluncus spp.; N. periodontitis, with abstsedyruvanni paradontu - 500 mg chubby g / day for 12 - 14 days of normal and acne globular chubby 500 mg 1 g / day as a supportive therapy for 8 weeks, the duration of treatment of streptococcal infections at least 10 days. The main effect of pharmaco-therapeutic effects of drugs: A / B broad-spectrum, active against gram (+) aerobic m / o: cocci - Staph. Breast Cancer 1 (human gene and protein) including Str. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, pseudomembranous colitis, rash, itching, hives, angioedema, anaphylactic shock, temporary paresthesia, deviation from normal liver function tests, Mr hemolysis, vasculitis, including Purpura Henoch-Shenlyayna. Contraindications to the use of drugs: hypersensitivity to the drug; lactation. Indications for use drugs: ear infections, nose, throat: sore throat and pharyngitis, otitis media, sinusitis, laryngitis and diphtheria (in addition to the treatment chubby diphtheria antitoxin), and scarlet fever in the case of penicillin allergy or intolerance, respiratory tract infections: whooping cough, G bronchitis, pneumonia, including atypical pneumonia, psittacosis, dental infections: gingivitis and other dental infections, skin infections and soft tissue: pyoderma, furunculosis, anthrax, beshyhove inflammation (in the case of penicillin allergy or intolerance ), acne, lymphangitis, lymphadenitis, urinary tract infection: limfohranuloma deployed, urethritis, prostatitis, cervicitis, endometritis, gonorrhea, chlamydia, mycoplasma infection and syphilis (in the case of penicillin allergy or intolerance). Method of production of drugs: Table.